DOUGLAS Group grows sales in Q2 and updates full-year guidance on adjusted EBITDA – Biotech Investments

by Biotech Newsroom


DOUGLAS Group grows sales in Q2 and updates full-year guidance on adjusted EBITDA

The issuer is solely responsible for the content of this announcement.

Q2 2025/26 Trading Statement

DOUGLAS Group grows sales in Q2 and updates full-year guidance on adjusted EBITDA

  • Market: Premium beauty with slower growth rates in mature markets, shifting shopping behavior, and increased focus on pricing and promotion amid customer uncertainty
  • Higher sales at lower margin in Q2: Based on preliminary figures, Group sales increased by 1.1% to 949.7 million…



Source link

You may also like

Houston, TX – (EmailWire) — The Biotech Times™ aggregates, publishes and distributes news about the Biotech Industry. In association with EmailWire™, The Biotech Times, helps businesses and organizations in the industry with press release distribution. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us through the following messaging apps:

Free Magazines

Recent Articles

BioTech Times™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC